Galmed Pharmaceuticals (GLMD) Institutional Ownership $1.55 -0.03 (-1.85%) Closing price 10/8/2025 03:59 PM EasternExtended Trading$1.55 0.00 (-0.05%) As of 10/8/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)CurrentInstitutional OwnershipPercentage76.14%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$81.03KNumber ofInstitutional Sellers(last 12 months)0 Get GLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data GLMD Institutional Buying and Selling by Quarter Galmed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Schonfeld Strategic Advisors LLC25,400$81K0.0%N/A3.969% 5/7/2024CVI Holdings LLC74,665$25K0.0%-72.3%1.479% 8/15/2023BVF Inc. IL89,853$261K0.0%-93.3%5.348% 5/16/2023BVF Inc. IL1,347,755$575K0.0%-22.5%5.348% 7/18/2022Western Wealth Management LLC59,074$38K0.0%N/A0.235% 2/8/2022Raymond James & Associates203,540$370K0.0%-11.4%0.811% 2/7/2022Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485% 11/16/2021Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101% 11/16/2021Toroso Investments LLC24,657$69K0.0%N/A0.098% 11/5/2021Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756% 11/2/2021Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085% 11/2/2021Raymond James & Associates229,640$641K0.0%+10.5%0.915% 8/16/2021Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130% 8/16/2021Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766% 8/16/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867% (Data available from 1/1/2016 forward) GLMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLMD shares? During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: Schonfeld Strategic Advisors LLC ($81K), CVI Holdings LLC ($25K).Learn more on Galmed Pharmaceuticals' institutional investors. What percentage of Galmed Pharmaceuticals' stock is owned by institutional investors? 76.14% of Galmed Pharmaceuticals' stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings. Which institutional investors have been buying Galmed Pharmaceuticals' stock? The following institutional investors have purchased Galmed Pharmaceuticals' stock in the last 24 months: Schonfeld Strategic Advisors LLC ($25.40K). How much institutional buying is happening at Galmed Pharmaceuticals? Institutional investors have bought a total of 25,400 shares in the last 24 months. This purchase volume represents approximately $81.03K in transactions. Related Companies KPRX Institutional Ownership HCWB Institutional Ownership ERNA Institutional Ownership QLGN Institutional Ownership CELZ Institutional Ownership APRE Institutional Ownership RNAZ Institutional Ownership VYNE Institutional Ownership BCDA Institutional Ownership PALI Institutional Ownership This page (NASDAQ:GLMD) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
